T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells.
about
Interaction of human immunodeficiency virus gp120 with the voltage-gated potassium channel BEC1Restricting HIV-1 pathways for escape using rationally designed anti–HIV-1 antibodiesEscape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness lossFitness ranking of individual mutants drives patterns of epistatic interactions in HIV-1The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal ApplicationsEnhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter.Genotypic and functional properties of early infant HIV-1 envelopesHIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.Human immunodeficiency virus type 1 variants resistant to first- and second-version fusion inhibitors and cytopathic in ex vivo human lymphoid tissue.In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10.Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.Broadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virusFunctional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma virusesPan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian ArtichokeAqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion density.Measuring HIV fusion mediated by envelopes from primary viral isolates.Monitoring early fusion dynamics of human immunodeficiency virus type 1 at single-molecule resolution.Clinical significance of human immunodeficiency virus type 1 replication fitness.Enhanced fusion and virion incorporation for HIV-1 subtype C envelope glycoproteins with compact V1/V2 domainsSubtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection.CIB1 and CIB2 are HIV-1 helper factors involved in viral entry.Human immunodeficiency viruses: propagation, quantification, and storage.Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.Human immunodeficiency viruses: propagation, quantification, and storage.Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.Determinants of human immunodeficiency virus type 1 resistance to membrane-anchored gp41-derived peptides
P2860
Q24338928-AC2F350E-4B83-4047-9711-5F8F5651A713Q27678352-FCB7D413-DBD1-4DC6-BF61-C7DF68C09E6CQ28469223-8BF0236A-A9EB-4098-83FB-EA160543662CQ28477614-FA5D77BD-A7CD-4F87-B6E5-760210B86BC5Q28546014-EBC35029-E439-45B0-8C22-C88D16F3E699Q33521210-A0587FB4-EBEE-417B-9AFB-C7E396B3376FQ34485260-4B56DA67-F20E-461D-8CCC-FCDA06169094Q35289861-BDD0A052-C2A7-4968-8282-DA2A23B47377Q35640998-D32C8220-4997-44B2-B1C8-695A2872B5C8Q35857279-C0033450-BFD1-4772-8469-3262A1A1F563Q35947769-D58E945F-1AE8-403B-9361-A2E18546AB27Q36298503-977F5195-E3C4-481C-8DC5-80D43C6A3251Q36397394-DF3BF3C3-B8A3-43EB-A188-910FC83FE254Q36502557-ED8E91E1-E76C-4536-9EFB-18B750E30B73Q36524016-FF99F869-2D4C-4E2F-AA8C-D28BAD228E2AQ36528448-5A2CB8E7-7DE3-4AFE-B7E3-336064A143ACQ36585516-A25C948A-C598-4D7A-9F66-37EA72ECB467Q36747741-872D0A77-3EFC-4F7A-B970-96A1C218B4DEQ36969857-24E4F345-9868-4335-814B-DD5ADBCA351AQ37547162-4AC88745-3FE2-4BBC-8C95-903D2ECCFF5FQ37704735-4D5E1A20-DBF4-4E5D-9064-8DDC7465CE84Q39025979-5ED919D8-41E9-429E-B7BF-B38FD782001EQ39194888-ADE6D87F-115F-4C84-A19D-99FEDD29930DQ39808350-C468ABA9-949D-46F8-83FD-04AE3009CC4BQ39943480-81458D28-0420-43FB-8286-647AD35B4B43Q40334457-ED0CE958-715F-4DBA-988F-F8E99CF40DC3Q41874442-B875F9B5-57D9-4BE6-B0EE-DDEEA1182B24
P2860
T20-insensitive HIV-1 from naive patients exhibits high viral fitness in a novel dual-color competition assay on primary cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
T20-insensitive HIV-1 from nai ...... tition assay on primary cells.
@en
type
label
T20-insensitive HIV-1 from nai ...... tition assay on primary cells.
@en
prefLabel
T20-insensitive HIV-1 from nai ...... tition assay on primary cells.
@en
P2093
P1433
P1476
T20-insensitive HIV-1 from nai ...... tition assay on primary cells.
@en
P2093
Cynthia A Derdeyn
Isabel Hagmann
Marintha L Heil
Matthias T Dittmar
Sabine Lohrengel
Thomas Neumann
P304
P356
10.1016/J.VIROL.2004.12.035
P407
P577
2005-03-01T00:00:00Z